#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Italy The Netherlands +4

  • Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Italy The Netherlands +3

  • Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Hungary Italy +3

  • Study of amivantamab and pemetrexed for patients with non-small cell lung cancer who have EGFR exon20 insertion mutations and cannot receive platinum therapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Italy

  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Evaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Spain

  • Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain